Cooper C L, Malik K U
Br J Pharmacol. 1984 Jul;82(3):679-88. doi: 10.1111/j.1476-5381.1984.tb10807.x.
The relationship between the effects of glucocorticoids on renal vascular reactivity and prostaglandin synthesis elicited by noradrenaline (NA), angiotensin II (AII), arginine vasopressin (AVP) and bradykinin (Bk) was investigated in the isolated kidney of the rat perfused with Tyrode solution. Administration of NA 0.3-3.0 nmol, AII 0.028-0.28 nmol, AVP 0.027-0.27 nmol and Bk 0.28-2.8 nmol enhanced in a dose-dependent manner the renal output of immunoreactive prostaglandin E2 (PGE2) and 6-keto-PGF1 alpha. NA, AII and AVP, but not Bk, produced renal vasoconstriction and increased perfusion pressure. In the presence of dexamethasone (2.6 X 10(-5)M) or corticosterone (2.9 X 10(-5) M), the effects of NA and AII, in enhancing prostaglandin synthesis and producing renal vasoconstriction, were reduced. In contrast, stimulation of prostaglandin synthesis by Bk and AVP and the renal vasoconstriction produced by AVP were not altered by the glucocorticoids. Dexamethasone or corticosterone did not alter the output of prostaglandins elicited by A-23187 or arachidonic acid (AA). Addition of mepacrine (2.1 X 10(-5)M) to the perfusion fluid reduced the renal output of prostaglandins elicited by the vasoactive hormones and by A-23187, but not by AA; the vasoconstrictor response to NA and AII, but not to AVP was reduced. In kidneys in which prostaglandin synthesis was inhibited by indomethacin (2.8 X 10(-6)M), administration of dexamethasone also reduced the renal vasoconstrictor effect of NA and AII. These data indicate that in Tyrode-perfused rat kidney the glucocorticoids dexamethasone and corticosterone exert a differential effect on the renal vascular reactivity to vasoactive hormones, and that their inhibitory effect on NA and AII-induced renal vasoconstriction appears to be unrelated to prostaglandin synthesis.
在以台氏液灌注的大鼠离体肾脏中,研究了糖皮质激素对去甲肾上腺素(NA)、血管紧张素II(AII)、精氨酸加压素(AVP)和缓激肽(Bk)引起的肾血管反应性与前列腺素合成的影响之间的关系。给予0.3 - 3.0 nmol的NA、0.028 - 0.28 nmol的AII、0.027 - 0.27 nmol的AVP和0.28 - 2.8 nmol的Bk,可使免疫反应性前列腺素E2(PGE2)和6 - 酮 - PGF1α的肾输出量呈剂量依赖性增加。NA、AII和AVP(而非Bk)可引起肾血管收缩并使灌注压升高。在存在地塞米松(2.6×10⁻⁵M)或皮质酮(2.9×10⁻⁵M)的情况下,NA和AII在增强前列腺素合成及产生肾血管收缩方面的作用减弱。相比之下,糖皮质激素并未改变Bk和AVP对前列腺素合成的刺激作用以及AVP所产生的肾血管收缩作用。地塞米松或皮质酮并未改变由A - 23187或花生四烯酸(AA)引起的前列腺素输出量。向灌注液中添加氯喹(2.1×10⁻⁵M)可降低血管活性激素和A - 23187所引起的前列腺素肾输出量,但不影响AA所引起的;对NA和AII的血管收缩反应减弱,但对AVP的无影响。在前列腺素合成被吲哚美辛(2.8×10⁻⁶M)抑制的肾脏中,给予地塞米松也可降低NA和AII的肾血管收缩作用。这些数据表明,在台氏液灌注的大鼠肾脏中,糖皮质激素地塞米松和皮质酮对肾血管对血管活性激素的反应性具有不同作用,且它们对NA和AII诱导的肾血管收缩的抑制作用似乎与前列腺素合成无关。